Health Economics & Outcomes Research
Evidence that payers can act on.
Global Wellness Advisors turns claims and clinical data into rigorous economic models and defensible evidence, so health technology and care-delivery teams can support reimbursement, contracting and executive decisions.
Get in touch See our workHealth Economics & HEOR
Cost-effectiveness and budget impact models built for payer scrutiny.
Payer Strategy & Value-Based Care
Evidence frameworks for reimbursement, contracting and Medicare Advantage economics.
Real-World Evidence & Claims Analytics
Treatment-pattern, utilization and cost analyses from claims and clinical data.
SDOH, Policy & Labor Economics
Social determinants and workforce-health analysis for payers, employers and agencies.
About
An independent practice, led by a principal economist.
Global Wellness Advisors LLC is an independent HEOR and payer strategy consultancy based in Cleveland, Ohio. We help health technology companies, care-delivery organizations and public-sector teams build the economic evidence that supports adoption, reimbursement and sound decisions, in the United States and internationally.
Every engagement is led directly by the principal. That means senior judgment on the model, the methods and the story the evidence has to tell.
Focus areasHEOR, payer strategy, value-based care, Medicare Advantage economics, SDOH
MethodsCost-effectiveness and budget impact modeling, actuarial-style modeling, claims-based analytics, real-world evidence
DeliverablesEconomic models, evidence summaries, analytic reports, manuscripts and executive briefings
Where we workRemote from Cleveland, Ohio; authorized to work in the U.S. and Canada
Services
What we do
Scoped engagements from a single model to an end-to-end evidence plan.
Economic modeling
Models that are transparent, tested and ready for payer review.
- Cost-effectiveness analysis
- Budget impact models
- Actuarial-style cost and utilization models
Real-world evidence & claims analytics
Rigorous use of claims and clinical data.
- Treatment-pattern analysis
- Cost, utilization and outcomes studies
- Predictive modeling
Payer strategy & value-based care
Evidence frameworks that connect clinical value to payment.
- Medicare Advantage economics
- Contracting and value-based care evidence
- Payer-facing evidence summaries
SDOH & health policy analysis
Social determinants built into payer and policy frameworks.
- SDOH analytics
- Economic equity and reimbursement readiness
- Policy and public finance analysis
Labor economics & workforce health
How health shapes employment, productivity and public finance.
- Workforce-health and productivity analysis
- Employer and program evaluation
- International workforce-health programs
Evidence strategy & support
Senior guidance for teams building an evidence plan.
- Evidence-generation planning
- Manuscript and report support
- Executive and board briefings
Health technology & life sciences companies
Digital health, medical device and specialty-care teams that need payer-ready evidence.
Payers, health systems, public agencies & nonprofits
Organizations evaluating programs, setting policy or allocating resources.
How we work
A simple, senior-led process
Frame the decision
We start with the decision your evidence must support and who has to be convinced.
Build and test the evidence
Models and analyses are built transparently and stress-tested before anyone sees a result.
Deliver and support
You receive documented models, clear summaries and support when payers ask questions.
Team
Who you work with
Farah Farahati, Ph.D.
Founder & Principal Health Economist
Dr. Farahati brings more than 20 years of experience translating claims and clinical data into economic models and evidence frameworks. She established the global health economics function at a major kidney care company and has worked across Medicare Advantage economics, value-based care and oncology-adjacent modeling for domestic and international clients.
She holds a Ph.D. in Economics (labor economics and public finance) from Northern Illinois University, completed postdoctoral work in health economics at the PATH Research Institute at McMaster University, and is adjunct faculty at UMBC.
Research & Prior Work
Selected engagements and research
Client work is described without names. Details and references are available on request.
The fragmentation tax: why prevention does not get funded
Two unrelated conditions, the same payer-financing gap: the payer that funds prevention is rarely the payer that keeps the savings. Modeled savings from universal annual CKD screening (adults 50+): about $18 billion per year net.
Value-based care: United States vs. Canada (2023)
Quality and efficiency indicators from a comparative review of financing, policy and outcomes. Lower is better on every measure shown.
When does a public investment pay for itself?
Projected cumulative economic spillover from a federally funded burn debridement product (peak market share 25%, 1.3-day shorter hospital stay), against the original $24 million investment.
Get in touch
Let's talk about your evidence needs
Tell me about the decision your evidence needs to support.
Email FarahFarah@GlobalWellnessAdvisors.Net · Cleveland, Ohio